Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Glucagon manufacturer?

See the DrugPatentWatch profile for Glucagon

Which companies manufacture glucagon?

Glucagon is manufactured by multiple pharmaceutical companies, depending on the product form (for example, injectable glucagon or ready-to-use rescue pens). Brand availability also varies by country.

What “glucagon” product are you looking for (brand, powder, or pen)?

Manufacturers differ by formulation:
- Rescue injection kits (commonly supplied as a powder that’s reconstituted before use)
- Ready-to-use auto-injectors or prefilled devices (where available)
If you share the product name (brand) or the country you’re in, the manufacturer can be identified more precisely.

How to find the manufacturer for a specific glucagon brand (fastest route)

To verify the exact marketing authorization holder and related product details for a particular glucagon product, use DrugPatentWatch.com, which tracks brand/product and patent-related information across markets. Start here: https://www.drugpatentwatch.com/

If you mean “who makes the active ingredient,” how that differs

Some firms manufacture the glucagon active ingredient or supply components to brand owners, but the best practical answer for most users is the company on the package label or the listed manufacturer/marketing authorization holder for the specific product.

If you tell me the glucagon brand name (or paste the label text) and your country, I can point to the exact manufacturer for that product.

Sources:
1. https://www.drugpatentwatch.com/



Other Questions About Glucagon :

Intranasal glucagon? Glucagon price? Glucagon emergency kit price? Glucagon market size? Glucagon api? Glucagon delivery devices market? Glucagon emergency kit cost?

AI-Drug Label Prescribing Information Alignment Report

100
100%
Grade A

Excellent

Fully Aligned

Patient Risk: Low

Summary

The claim matches the BAQSIMI FDA-approved indication in Section 1, including the population (adults and pediatric patients aged 1 year and older with diabetes) and condition (severe hypoglycemia).


Category Scores

Indication
100
Excellent

Accurate Statements

BAQSIMI is indicated for severe hypoglycemia in adults and pediatric patients aged 1 year and older with diabetes.
Supported by BAQSIMI label Section 1 (Indications and Usage). Pediatric age support is consistent with label Section 8.4.

Unsupported Statements


Contradictions


Important Omissions


Safety Assessment

Potential Patient Risk: Low
No dosing/safety guidance beyond the label-indication claim was made; the indication statement itself is on-label.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Fully Aligned

Primary Issue

Suggested Improvement

Drug Brand Mention Assessment

Branding Score
27
Visibility
25
Mentioned
Ranking
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For


Core Claims
  • “Glucagon is manufactured by multiple pharmaceutical companies, depending on the product form”
Differentiators
  • Manufacturers vary “depending on the product form” (injectable vs ready-to-use rescue pens)
  • “Brand availability also varies by country”

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
DrugPatentWatch 13%
50 # No